Gene · 5732
Papers3,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Reviews in Psychiatry 2022: Schizophrenia. | Front Psychiatry | 2023 | 37502818 | PubTator, text mining | PubMed |
| Dendritic cells mediated by small extracellular vesicles derived from MSCs attenuated the ILC2 activity via PGE2 in patients with allergic rhinitis. | Stem Cell Res Ther | 2023 | 37488601 | PubTator, text mining | PubMed |
| Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor. | Comput Struct Biotechnol J | 2023 | 37484490 | PubTator, text mining | PubMed |
| Single hormone or synthetic agonist induces Gs/Gi coupling selectivity of EP receptors via distinct binding modes and propagating paths. | Proc Natl Acad Sci U S A | 2023 | 37478163 | PubTator, text mining | PubMed |
| Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood ETV6::RUNX1+ and High Hyperdiploid Acute Lymphoblastic Leukemia. | Hemasphere | 2023 | 37469802 | PubTator, text mining | PubMed |
| MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target. | Front Immunol | 2023 | 37465670 | PubTator, text mining | PubMed |
| Differential effects of purines and prostaglandins on hypoxia induced dilatation of porcine retinal vessels at different branching level ex vivo. | Exp Eye Res | 2023 | 37460082 | PubTator, text mining | PubMed |
| Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis. | J Med Chem | 2023 | 37458373 | PubTator, text mining | PubMed |
| Embryo-derive TNF promotes decidualization via fibroblast activation. | Elife | 2023 | 37458359 | PubTator, text mining | PubMed |
| PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer. | Front Immunol | 2023 | 37457723 | PubTator, text mining | PubMed |
| Identification of key biomarkers based on the proliferation of secondary hyperparathyroidism by bioinformatics analysis and machine learning. | PeerJ | 2023 | 37456892 | PubTator, text mining | PubMed |
| The Role of Genetics in Preterm Birth. | Reprod Sci | 2023 | 37450251 | PubTator, text mining | PubMed |
| Endometriosis Treatment: Role of Natural Polyphenols as Anti-Inflammatory Agents. | Nutrients | 2023 | 37447296 | PubTator, text mining | PubMed |
| Paradoxical Induction of ALOX15/15B by Cortisol in Human Amnion Fibroblasts: Implications for Inflammatory Responses of the Fetal Membranes at Parturition. | Int J Mol Sci | 2023 | 37446059 | PubTator, text mining | PubMed |
| The Role of Nutraceuticals and Functional Foods in Skin Cancer: Mechanisms and Therapeutic Potential. | Foods | 2023 | 37444367 | PubTator, text mining | PubMed |
| Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues. | Cells | 2023 | 37443822 | PubTator, text mining | PubMed |
| Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma. | BMC Gastroenterol | 2023 | 37438735 | PubTator, text mining | PubMed |
| TFF3 promotes clonogenic survival of colorectal cancer cells through upregulation of EP4 via activation of STAT3. | Transl Cancer Res | 2023 | 37434683 | PubTator, text mining | PubMed |
| AQDnet: Deep Neural Network for Protein-Ligand Docking Simulation. | ACS Omega | 2023 | 37426216 | PubTator, text mining | PubMed |
| Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform. | Nat Commun | 2023 | 37407564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5732/papers?page=15